What medications can patients with cerebral infarction use?

Generally speaking, cerebral infarction is a disease caused by cerebral vascular occlusion leading to cerebral tissue ischemia and hypoxia. Common symptoms include limb weakness, slurred speech, dizziness, facial droop, and others. Patients may take medications under medical guidance, such as aspirin enteric-coated tablets, clopidogrel hydrogen sulfate tablets, atorvastatin calcium tablets, cytidine diphosphate-choline sodium tablets, and edaravone injection. Detailed explanations are as follows:

1. Aspirin Enteric-Coated Tablets

These belong to antiplatelet drugs that inhibit platelet aggregation, preventing thrombus formation and avoiding worsening of cerebral vascular occlusion or new clot formation, while also preventing recurrence of cerebral infarction. They are suitable for long-term secondary prevention after the acute phase of cerebral infarction and may be used in combination with other antiplatelet drugs during the acute phase. Dosage should be followed as instructed to avoid gastrointestinal discomfort caused by overdose.

2. Clopidogrel Hydrogen Sulfate Tablets

This is also an antiplatelet drug that exerts antiplatelet effects by blocking ADP receptors on the platelet surface, inhibiting thrombus formation. It is suitable for patients with cerebral infarction who are intolerant to or have contraindications for aspirin, or for use in combination with aspirin during the acute phase of cerebral infarction to enhance antiplatelet effects and reduce the risk of thrombus recurrence. Bleeding tendency should be monitored during medication.

3. Atorvastatin Calcium Tablets

This belongs to the statin class of lipid-lowering drugs, which can reduce low-density lipoprotein cholesterol levels in the blood, stabilize atherosclerotic plaques, prevent plaque rupture-induced thrombosis, and improve vascular endothelial function. Regardless of baseline lipid levels, long-term administration can prevent the progression of atherosclerosis and reduce the recurrence rate of cerebral infarction in patients.

4. Cytidine Diphosphate-Choline Sodium Tablets

This is a cerebral metabolism-improving drug that participates in phospholipid synthesis, promotes cerebral cell metabolism, improves cerebral blood circulation, reduces ischemic and hypoxic injury to brain tissue, and aids in the recovery of neurological function. It is suitable for patients during the recovery phase of cerebral infarction, alleviating symptoms such as limb dysfunction and memory decline, promoting neurological function recovery, and improving patients' quality of life.

5. Edaravone Injection

This belongs to free radical scavengers, which can eliminate large amounts of free radicals produced during the acute phase of cerebral infarction, reduce oxidative damage to brain tissue, inhibit cerebral edema and ischemic necrosis of brain tissue, and protect nerve cells. It is suitable for patients during the acute phase of cerebral infarction (within 48 hours of onset), administered intravenously, improving patients' neurological deficit symptoms and laying the foundation for subsequent rehabilitation.

Normally, maintain a low-salt, low-fat diet and avoid foods such as fatty meats and fried foods. Quit smoking and limit alcohol consumption to reduce vascular injury factors. Under a physician's guidance, undergo rehabilitation training such as limb function exercises and language therapy. Regularly monitor blood pressure, blood glucose, and lipid levels to control underlying diseases and prevent recurrence of cerebral infarction. If sudden worsening of limb weakness or slurred speech occurs, seek immediate medical attention.